# Pharmaxis Ltd.: Form D filing

Pharmaxis Ltd., a pharmaceuticals company in New South Wales, filed a Form D with the SEC in 2009. The latest, on June 19, 2009, reports $1.4 million sold of a $1.4 million offering to 2 investors.

Find out what Pharmaxis Ltd. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Pharmaxis%20Ltd.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Pharmaxis%20Ltd.&page=%2Fdata%2Fform-d%2Fcompany%2Fpharmaxis-ltd-1301357)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Pharmaxis%20Ltd.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Pharmaxis%20Ltd.&page=%2Fdata%2Fform-d%2Fcompany%2Fpharmaxis-ltd-1301357)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals
- [Form D filings](https://specstream.ai/data/form-d): 44,302 rows, by operating companies, filed since November 1, 2024, $523.02, or the new rows each week for $92.05 a month. Buy: https://specstream.ai/data/form-d

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 2/10 RODBOROUGH ROAD, FRENCHS FOREST, New South Wales, 2086
- Phone: 61 (2) 9454 7203
- Industry: Pharmaceuticals
- Entity type: Other
- Incorporated in: Australia
- Revenue range: $5,000,001 - $25,000,000
- Exemptions claimed: Rule 506
- SEC identifier (CIK): 1301357

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Jun 19, 2009 | New notice | $1,394,437 | $1,394,437 | $0 | 2 | Jun 4, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1301357/000130135709000001/0001301357-09-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| John F. Crapper | Executive Officer |  |
| Ian A. McDonald | Executive Officer |  |
| Peter C. Farrell | Director |  |
| William Delaat | Director |  |
| Malcom J. McComas | Director |  |
| Brett Charlton | Executive Officer |  |
| John Villiger | Director |  |
| Alan D. Robertson | Executive Officer, Director |  |
| David M. McGarvey | Executive Officer |  |
| Denis M. Hanley | Director |  |
| Gary J. Phillips | Executive Officer |  |

[Every Form D from the week of Jun 15, 2009](https://specstream.ai/data/form-d/week/2009-06-15) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what Pharmaxis Ltd. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).